During the past decade, SKDS Research Inc. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 14 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 7 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SKDS Research Inc." #1 sponsor was "Pfizer" with 4 trials, followed by "Population Health Research Institute" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Antibe Therapeutics Inc." with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SKDS Research Inc." #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "Canadian Stroke Network" with 1 trials as a collaborator, "Canadian Stroke Prevention Intervention Network" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "SKDS Research Inc." are "Atrial Fibrillation" (2 trials), "Influenza" (2 trials), "Osteoarthritis" (2 trials), "Aggression" (1 trials) and "Agitation" (1 trials). Many other conditions were trialed in "SKDS Research Inc." in a lesser frequency.

Most popular intervention types in "SKDS Research Inc." are "Drug" (16 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "1% SPL7013 Gel" (1 trials), "30 Second Pulse Check" (1 trials), "40 mg Laninamivir Octanoate" (1 trials) and "80 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "SKDS Research Inc." are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SKDS Research Inc.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in SKDS Research Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in SKDS Research Inc., 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".